Increased Selenoprotein P Levels in Subjects with Visceral Obesity and Nonalcoholic Fatty Liver Disease - Concepedia

Concepedia

Publication | Open Access

Increased Selenoprotein P Levels in Subjects with Visceral Obesity and Nonalcoholic Fatty Liver Disease

DOI Full Paper Access

105

Citations

24

References

2013

Year

Hae Yoon Choi, Soon Young Hwang, Chang Hee Lee, Ho Cheol Hong, Sae Jeong Yang, Hye Jin Yoo, Ji A Seo, Sin Gon Kim, Nan Hee Kim, Sei Hyun Baik,

Diabetes & Metabolism Journal

Abstract

Circulating SeP levels were increased in subjects with NAFLD as well as in those with visceral obesity and may be a novel biomarker for NAFLD.

References

	Year	Citations
Increased oxidative stress in obesity and its impact on metabolic syndrome Shigetada Furukawa, Takuya Fujita, Michio Shimabukuro, Journal of Clinical Investigation	2004	5.2K
Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease Vlad Ratziu, Frédéric Charlotte, A. Heurtier, Gastroenterology HepatologyNonalcoholic Fatty Liver DiseaseLiver PhysiologyHistopathologyDiagnosis	2005	2K
New Criteria for `Obesity Disease' in Japan The Examination Committee of Criter Circulation Journal	2002	1.6K
Serum FGF21 Levels Are Increased in Obesity and Are Independently Associated With the Metabolic Syndrome in Humans Xinmei Zhang, Dennis C.Y. Yeung, Michal Karpíšek, Diabetes	2008	883
Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: A role for insulin resistance and diabetes Anna Ludovica Fracanzani, Luca Valenti, Elisabetta Bugianesi, Hepatology	2008	698
Increased Fibroblast Growth Factor 21 in Obesity and Nonalcoholic Fatty Liver Disease Jody Dushay, Patricia C. Chui, Gosala Gopalakrishnan, Gastroenterology ObesityMetabolic SyndromeFibrosisMetabolic Associated SteatohepatitisHepatology	2010	580
Prevalence and Determinant Factors of Sarcopenia in Patients With Type 2 Diabetes Tae Nyun Kim, Man Sik Park, Sae Jeong Yang, Diabetes Care	2010	576
Visceral adiposity and risk of type 2 diabetes: a prospective study among Japanese Americans. Edward J. Boyko, Wilfred Y. Fujimoto, Donna L. Leonetti, Diabetes Care	2000	573
A Liver-Derived Secretory Protein, Selenoprotein P, Causes Insulin Resistance Hirofumi Misu, Toshinari Takamura, Hiroaki Takayama, Cell Metabolism Metabolic SyndromeHepatologyBiochemistryLiver PhysiologyDiabetes	2010	560
α2-Heremans-Schmid Glycoprotein/ Fetuin-A Is Associated With Insulin Resistance and Fat Accumulation in the Liver in Humans Norbert Stefan, Anita M. Hennige, Harald Staiger, Diabetes Care	2006	462

Page 1